Studies on Stem Cells Research and Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Valarmathi Mani Thiruvanamalai
    Department of Comparative Biosciences
    University of Illinois
    USA
    valarmathi64@hotmail.com
    SSCRT

    Research Interest: Cardiac Therapy, Cardiovascular Disease, Autologous, Tissue-Engineering, Multipotent Stem Cells, Cardiovascular Structures, Regenerative Medicine.

    More Info.
    Yuval Rinkevich
    Department of Pathology
    Stanford University
    USA
    yuvalrinkevich@gmail.com
    SSCRT

    Research Interest: Regenerative Biology (Marine Invertebrates and Mammals), Stem Cell Biology, Developmental Biology.

    More Info.
    Han Wang
    Department of Cellular and Structural Biology
    University of Texas
    USA
    cherrywangh@hotmail.com
    SSCRT

    Research Interest: Embryonic Stem Cells, Pluripotency, Induced Pluripotent Cells, Differentiation, Endoderm, Beta Cell, Diabetes, Obesity, Adipose Tissue, Brown Fat, Endothelium, Oxidative Stress, Nitric Oxide, Peroxynitrite, Superoxide, Nanosensors.

    More Info.
    Xia Pu
    Department of Biochemistry and Molecular Biology
    China Medical University
    China
    nn001007@163.com
    SSCRT

    Research Interest: Cancer Stem Cell, such as Surface Marker, Biology, and Mechanism.

    More Info.
    Milton Artur Ruiz
    VP South and Central America International Society for Cellular Therapy
    Brazil
    milruiz@yahoo.com.br
    SSCRT

    Research Interest: Hematopoietic Stem Cell Transplanting, Cell Therapy and Everything in the Field of Publication and Education.

    More Info.
    Ming Li
    Associate Professor
    Department of Stem Cell Disorders
    Kansai Medical University
    Japan
    lg6763@yahoo.co.jp
    SSCRT

    Research Interest: Focuses on Aging-Related Diseases and Stem Cell Transplantation. 

    More Info.
    Filomain Nguemo
    Institute of Neurophysiology
    Medical School University of Cologne
    Germany
    filo.nguemo@uni-koeln.de
    SSCRT

    Research Interest: Therapeutic Application of ES and Ips Cells.

    More Info.
    Edgar Grinstein
    Ph.D., Senior Scientist
    Center for Child and Adolescent Health
    Heinrich Heine University, Dusseldorf
    Germany
    Edgar.Grinstein@uni-duesseldorf.de
    SSCRT

    Dr. Edgar Grinstein is a Principal Investigator at the Heinrich Heine University in Düsseldorf (Germany). He researches hematopoietic stem cells and progenitor cells, signal transduction, gene transcription regulation. He has more than 11 years of experience as Editor-In-Chief at SAGE Publications Inc. (USA) and Libertas Academica (New Zealand), and also serves as Deputy Editor-In-Chief for Baishideng Publishing Group (USA).

    Raised in a family of researchers – both parents are PhD scientists - he received his PhD summa cum laude in Molecular Biology from the Humboldt University and the Max-Delbrück Center for Molecular Medicine in Berlin. He has published a number of papers in high-ranking journals and received a highly regarded Research Award from Dr.-Günther- and Imme-Wille-Foundation. Dr. Grinstein qualified as Professor in Molecular Medicine at the University of Düsseldorf in 2008 and is a Visiting Professor at the University of Latvia (Latvia, European Union) since 2010.  

    Dr. Grinstein`s research in the field of hematopoietic stem and progenitor cells, funded by research grants from German Research Foundation (DFG) and José Carreras Leukämie-Stiftung (José Carreras Foundation), has focused on markers, signal transduction and transcriptional control. Among other important findings made, his research group provided new insights into the role of the prominent surface marker AC133/CD133 (Leukemia 2015; 29: 2208-2220), that is expressed on stem/progenitor cells in normal hematopoiesis as well as on tumor-initiating cells in certain hematological malignancies. The study analyzed the control of AC133/CD133 expression in hematopoietic stem/progenitor cells, and revealed the impact thereof on molecular network relevant to these cells.

    Research Interest: hematopoietic stem cells and progenitor cells, cancer stem cells, stem cell markers, signal transduction, cell cycle control, regulation of apoptosis, gene transcription regulation

    Grants: Principal Investigator of stem cell-related projects funded by German Research Foundation (DFG) and by José Carreras Leukämie-Stiftung (José Carreras Foundation)

    URL: https://www.wjgnet.com/2218-6204/MemberDetail/42530

    publications:

    Grinstein, E., and H.-D. Royer. 1995. Multiple octamer-binding proteins are targets for the cell cycle regulated nuclear inhibitor I-92. DNA Cell Biol. 14: 493-500.

    Grinstein, E., I. Weinert, B. Droese, M. Pagano, and H.-D. Royer. 1996. Cell cycle regulation of nuclear factor p92 DNA-binding activity by novel phase-specific inhibitors. J. Biol. Chem. 271: 9215-9222.

    Bargou, R.C., C. Wagener, K. Bommert, W. Arnold, P.T. Daniel, M.Y. Mapara, E. Grinstein, H.-D. Royer, and B. Dörken. 1996. Blocking of transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J. Exp. Med. 183: 1205-1213.

    Bargou, R.C., F. Emmerich, D. Krappmann, K. Bommert, M.Y. Mapara, W. Arnold, H.-D. Royer, E. Grinstein, A. Greiner, C. Scheidereit, and B. Dörken. 1997. Constitutive nuclear factor kappaB-RelA activation is required for proliferation and survival of Hodkin’s desease tumor cells. J. Clin. Invest. 12: 2961-2969.

    Janke, J., K. Schlüter, B. Jandrig, M. Theile, K. Kölble, W. Arnold, E. Grinstein, A.  Schwartz, L.E. Schwarz, P.M. Schlag, B.M. Jockusch, and S. Scherneck. 2000. Suppression of tumoriginecity in breast cancer cells by the microfilament protein profilin1. J. Exp. Med. 191: 1675-1685.

    Grinstein, E.,* F. Jundt, I. Weinert, P. Wernet, and H.-D. Royer. 2002. Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells. Oncogene. 21: 1485-1492.

    Grinstein, E., P. Wernet, P.J. Snijders, F. Rösl, I. Weinert, W. Jia, R. Kraft, Ch. Schewe, M. Schwabe, S. Hauptmann, M. Dietel, Ch. Meijer, and H.-D. Royer. 2002. Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J. Exp. Med. 196: 1067-1078.

    Grinstein, E.,* Y. Shan, L. Karawajew, P.J. Snijders, C.J. Meijer, H.-D. Royer, and P. Wernet. 2006. Cell cycle controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation.  J. Biol. Chem. 281: 22223-22235.

    Grinstein, E.,* Y. Du, S. Santourlidis, J. Christ, M. Uhrberg, and P. Wernet. 2007. Nucleolin regulates gene expression in CD34 positive hematopoietic cells. J. Biol. Chem. 282: 12439-12449.

    Grinstein, E.,* and P. Wernet. 2007. Cellular signaling in normal and cancerous stem cells. Cell. Signal. 19: 2428-2433.
    This was the most read article of the Journal Cell. Signal. from July 2007 till March 2008. Source: SCIENCEDIRECT TOP 25 HOTTEST ARTICLES

    Wethkamp, N., H. Hanenberg, C. Suschek, W. Wetzel, S. Heikaus, E. Grinstein, U. Ramp, R. Engers, H. Gabbert, and C. Mahotka. 2011. DAXX-beta and DAXX-gamma: two novel splice variants of the transcriptional co-repressor DAXX. J. Biol. Chem. 19576-19588.

    Grinstein, E.,* C. Mahotka, and A. Borkhardt. 2011. Rb and nucleolin antagonize in controlling human CD34 gene expression. Cell. Signal. 23: 1358-1365.

    Bhatia, S., S. Reister, C. Mahotka, R. Meisel, A. Borkhardt, and E. Grinstein.* 2015. Control of AC133 / CD133 and impact on human hematopoietic progenitor cells through nucleolin. Leukemia. 29: 2208-2220.

    Mahotka, C., S. Bhatia, J. Kollet, and E. Grinstein.* 2018. Nucleolin promotes execution of the hematopoietic stem cell gene expression program. Leukemia. 32: 1865–1868.

    Reister, S., C. Mahotka, N. van den Höfel, and  E. Grinstein.* 2019. Nucleolin promotes Wnt signaling in human hematopoietic stem/progenitor cells. Leukemia. 33: 1052-1054.


    More Info.
    Carolina Panis
    Nacional Instituto do Cancer
    State University of Londrina
    Brazil
    carolpanis@sercomtel.com.br
    SSCRT

    Research Interest: Actually Works as Young Researcher in Projects Regarding Genomics, Proteomics and Inflammatory Aspects of Human Breast Cancer and Chronic Diseases. 

    More Info.
    Xiefan Fang
    Department of Pediatrics
    University of Florida
    USA
    xiefanfang@ufl.edu
    SSCRT

    Research Interest: Cardiology, Toxicology, Epigenetics, Stem Cell Differentiation, and Bioinformatics.

    More Info.
    Yongqing Liu
    Assistant Professor
    Department of Ophthalmology and Visual Sciences
    University of Louisville
    USA
    yongqing.liu@louisville.edu
    SSCRT

    Research Interest: Cancer Stem Cells, Ocular Stem Cells

    More Info.
    Praveen Shukla
    Department of Radiology and Medicine
    Stanford University School of Medicine
    USA
    praveenniper@gmail.com
    SSCRT

    Research Interest: Drug Discovery and Development.

    More Info.
    XiuJun (James) Li
    University of Texas at El Paso
    USA
    xli4@utep.edu
    SSCRT

    Research Interest: Nanotechnology, Bioanalytical chemistry, infectious disease diagnosis, cellular analysis

    More Info.
    Jesus Vaquero
    Professor
    Department of Neurosurgery
    Autonomous University
    Spain
    jvaqueroc@telefonica.net
    SSCRT

    Research Interest: Neurological Disability.

    More Info.
    Toru Hosoda
    Associate Professor
    Tokai University
    Japan
    thosoda@zeus.bwh.harvard.edu
    SSCRT

    Research Interest: Resident Cardiac Stem Cells, Myocardial Regeneration in Basic and Clinical/Translational Studies.

    More Info.
    View more
    mendeley

    Stem Cell – De Novo Treatment Disorders

    DOI Logo 10.17352/sscrt.000018

    Published On: June 17, 2021 | Pages: 012 - 017

    Author(s): AD Diwan* and SN Harke
    Abstract View Full Article View    
    mendeley

    Potential therapeutic applications of mesenchymal stem cells for erectile dysfunction in diabetes mellitus: From preclinical/clinical perspectives

    DOI Logo 10.17352/sscrt.000017

    Published On: May 05, 2021 | Pages: 001 - 011

    Author(s): Serap Gur*
    Abstract View Full Article View    
    mendeley

    Tracking of Covid-19 in Libya

    DOI Logo 10.17352/sscrt.000016

    Published On: May 27, 2020 | Pages: 016 - 017

    Author(s): Aisha Nasef* and Adel El Taguri
    Abstract View Full Article View    
    mendeley

    Effect of culture environement on mesenchymal stem cell immunomodulatory ability

    DOI Logo 10.17352/sscrt.000015

    Published On: April 11, 2020 | Pages: 009 - 015

    Author(s): Aisha Nasef*, Alain Chapel and Loic Fouillard
    Abstract View Full Article View    
    mendeley

    Bovine whey improved the myocardial and lung damage of mother rats fed on a high fat diet

    DOI Logo 10.17352/sscrt.000014

    Published On: February 28, 2020 | Pages: 001 - 008

    Author(s): Hassan IH El-Sayyad*, Hebat A el-Ghawet, Khaled SM El-Bayomi and Eman Emara
    Abstract View Full Article View    
    mendeley

    The potential effects of pomegranate peel extract and bee venom in improving the diabetes induced damaging of spiral artery

    DOI Logo 10.17352/sscrt.000013

    Published On: December 27, 2019 | Pages: 007 - 011

    Author(s): El-Sayyad HIH*, El-Ghawet HA and El-Sayed AMA
    Abstract View Full Article View    
    mendeley

    Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group

    DOI Logo 10.17352/sscrt.000012

    Published On: August 03, 2019 | Pages: 000 - 006

    Author(s): Mehmet Ali Uçar*, Simten Dağdaş, Funda Ceran, Mesude Falay and Gülsüm Özet
    Abstract View Full Article View    
    mendeley

    Cell-Penetrating Peptides as a Tool to Deliver Biologically Active Recombinant Proteins to Generate Transgene-Free Induced Pluripotent Stem Cells

    DOI Logo 10.17352/sscrt.000011

    Published On: April 01, 2017 | Pages: 006 - 015

    Author(s): Chandrima Dey, Gloria Narayan, H Krishna Kumar, Manash P Borgohain, Nibedita Lenka and Rajkumar P Thummer*
    Abstract View Full Article View    
    mendeley

    Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence

    DOI Logo 10.17352/sscrt.000010

    Published On: December 31, 2016 | Pages: 001 - 005

    Author(s): Elgin OZKAN*, Mine ARAZ, Cigdem SOYDAL and Gulseren ARAS
    Abstract View Full Article View    
    mendeley

    Adipogenic and Osteogenic Markers Characterization of Human Amniotic Fluid Stem Cells

    DOI Logo 10.17352/sscrt.000009

    Published On: December 29, 2016 | Pages: 025 - 032

    Author(s): Hassan IH El-Sayyad*, Mohamed A Sobh, Soad A Khalifa, Omnia KRA El-Sayyad
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on SSCRT

    Google Reviews 11